Cardiology Letters 2012, 21(4):295-307
Long-term prognosis of patients after acute myocardial infarction in 2006-2007 from the Bratislava V district
- 1 IV. interná klinika LFUK a UNB, Nemocnica sv. Cyrila a Metoda v Bratislave
- 2 Oddelenia akútnej kardiológie, Národný ústav srdcových a cievnych chorôb a.s. v Bratislave, Slovenská republika
Aim of the study: The aim was to analyze clinical characteristics, treatment, and prognosis with regard to risk factors in patients with a history of acute myocardial infarction in 2006-2007 from the Bratislava V district and to determine the survival of these patients on average of 35 months after myocardial infarction.
Patients and Methods: From medical records we retrospectively analyzed a group of 155 patients from the Bratislava V district who were, from January 2006 to December 2007, hospitalized with acute myocardial infarction in Intensive Care Unit of 4th Department of Internal Medicine of St. Cyril and Methodius University Hospital in Bratislava, and the Department of Acute Cardiology of the National Institute of Cardiovascular Disease. On an average 35 months after myocardial infarction, we addressed 121 surviving patients with a questionnaire that was focused on the modifying risk factors of atherosclerosis, subjective difficulties and current treatment. Data were analyzed by statistical program JMP 7. We investigated distribution of survival rates with the Kaplan-Maier analysis.
Results: From a total of 155 patients hospitalized with acute myocardial infarction, there were 103 men and 52 women. The average age was 62.4 ± 12,5 years. We found in 89 (57.4%) cases a myocardial infarction with ST segment elevation and in 66 (42.6%) cases a myocardial infarction without ST segment elevation. Men dominated in the STEMI group (74%). Women with STEMI were significantly older (p=0.0006). We recorded the incidence of arterial hypertension, hyperlipidemia, and active smoking in 1/5 of the patients with STEMI. The incidence of arterial hypertension was more frequent in women (p=0.009), prevalence of hyperlipidemia was the same in both genders. There were more smokers among men compared to women (p=0,0007). Almost one quarter of patients with STEMI were diabetics. The incidence of diabetes between the sexes, despite the age difference, was not statistically significant. In the NSTEMI group we found out a history of arterial hypertension in 21 women, representing 91.3% of the total number of NSTEMI women (p=0.008). The proportion of male smokers in NSTEMI group was significantly higher than in women (48% versus 17%, p=0,008). Coronary angiography was performed in 77.5% of patients with STEMI and 42.4% of patients with NSTEMI. One-vessel disease was the most prevalent (45.9%), three-vessel disease was significantly more frequent in the NSTEMI group (39.3% versus 5.8%, p <0.001). Percutaneous coronary intervention was performed in 71.9% of STEMI patients and 10.6% of NSTEMI patients. GRACE score on admission correlated clearly with inpatient mortality (p<0.001). Inpatient mortality in the entire group was 10.9%: we found no significant difference between patients with STEMI (12.3%) and NSTEMI (9.1%) and a prevailing number of females in STEMI group (p=0.002). Late mortality rate 35 months after the first hospitalization was significantly higher in the NSTEMI than STEMI group (16.7% versus 6.7%, p<0.05). Overall, in the STEMI group, inpatient and late mortality was 19.0%, while in the NSTEMI group this increased to 25.8% (p=0.33). Hospitalization for recurrent myocardial infarction after discharge was higher in patients with NSTEMI (p=0.03). Survival curves showed worse prognosis of patients with NSTEMI (p=0.011), more significantly in males (p=0.017) - smokers and diabetics. We sent the questionnaire to 121 living patients and we received replies from 88 patients (72.7%). Despite myocardial infarction, nearly 26% of patients were active smokers, with a clear predominance of males (91.3% of smokers). Nearly 53% of patients had changed their diets, although 25% patients had increased their weight. Physical activity was comparable before and after myocardial infarction. Up to 63% of patients reported the occurrence of such difficulties as chest pain and breathlessness.
Conclusion: Treatment of patients with acute myocardial infarction is in accordance with generally accepted recommendations. The male population after NSTEMI in our study had a worse long-term prognosis compared with women in the same group. In addition to long-term drug therapy, the non-pharmacological modification of risk factors, which is not sufficient, is necessary. The number of patients with NSTEMI, who underwent coronary angiography and PCI is significantly low.
Keywords: acute myocardial infarction; percutaneous coronary intervention; risk factors for acute myocardial infarction; long-term prognosis of patients with STEMI and NSTEMI
Published: April 1, 2012 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- WHO Report 2008, The 10 leading causes of death by broad income group (2008), Geneva, s. 310. http://www.who.int/mediacentre/factsheets/fs310/en/
- Birkhead JS, Walker L, Pearson M, et al. Improving care for patients with acute coronary syndromes: initial results from the National audit of myocardial infarction project. Heart 2004;90:10041009.
Go to original source... - Kovář F, Studenčan M, Hricák V, et al. Manažment pacientov s akútnym koronárnym syndrómom bez elevácií segmentov ST. Analýza údajov registra SLOVAKS z roku 2008. Cardiology sk 2010;19(3):181-191.
- Studenčan M, Hricák V, Kovář F, et al. Význam cielených organizačných opatrení pre implementáciu oficiálnych odporúčaní pre manažment pacientov so STEMI do klinickej praxe. Analýza výsledkov registra SLOVAKS 2007-2008. Cardiology sk 2010;19(1):57-69.
- Unal B, Crichley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109(9):1101-1107.
Go to original source... - Ford ES. Explaining the decrease in U. S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356(23):2388-2399.
Go to original source... - Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice - a comparison of EUROASPIRE I, II and III surveys in eight European countries. Lancet 2009;373(9667):929-940.
Go to original source... - Wilson K, Gibson N, Wilson P, et al. Effect of smoking cessation on mortality after myocardial infarction - metaanalysis of cohort studies. Arch Intern Med 2000;160:939-944.
Go to original source... - Logue J, Walker JH, Colhoun M, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia 2011;54:3003-3006.
Go to original source... - Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009;6:60-75.
Go to original source... - Weitzman S, Wang C, Rosamond WD, et al. Is diabetes an independent risk factor for mortality after myocardial infarction? The ARIC Surveillence Study. Acta Diabetol 2004;41:77-83.
Go to original source... - Meisinger Ch, Heier M,von Scheidt W, et al. Gender-specific short and long-term mortality in diabetic versus nondiabetic patients with incident acute myocardial infarction in the reperfusion era (the MONICA/KORA myocardial infarction registry). Am J Cardiol 2010;106:1680-1684.
Go to original source... - Koek HL, de Briun A, Gast F, et al. Short and long/term prognosis after acute myocardial infarction in men versus women. Am J Cardiol 2006;98:993-999.
Go to original source... - Remišová S, Jurkovičová O, André I, et al. Liečba a včasná stratifikácia 342 pacientov s akútnym infarktom myokardu. Cardiol 2004;13(6):365-371.
- Studenčan M, Baráková A, Hlava P, et al. SLOVenský Register Akútnych Koronárnych Syndrómov - analýza údajov z roku 2007. Cardiol 2008;17(5):179-190.
- Madelzweig L, Batter A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes:characteristics, treatment and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285-2293.
Go to original source... - Widimský P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010;31:943-957.
Go to original source... - Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-1168.
Go to original source... - Goldberg RJ, Spencer FA, Gore JM, et al. Thirty-years (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population based perspective. Circulation 2009;119:1211-1219.
Go to original source... - Rasoul S, Ottervangen JP, Dambrink JH, et al. Are patients with non-ST elevation myocardial infarction undertreated? BMC Cardiovasc Disord 2007;7:8 http://www.biomedcentral.com/1471-2261/7/8.
Go to original source... - Chan MY,Sun JL,Newby K, et al. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 2009;189:3110-3117.
Go to original source... - Roe MT, Chen AY, Thomas L, et al. Predicting long-term mortality in older patients after non-ST-segment elevation myocardial infarction. Am Heart J 2011;162:875-883.
Go to original source... - Terkelsen CJ, Lassen JF, Norgaard BL, et al. Mortality rates in patients with ST elevation vs non ST elevation acute myocardial infarction: observation from an unselected cohort. Eur Heart J 2005;26:18-26.
Go to original source... - Allen LA, O´Donnell ChJ, Camargo C, et al. Comparison of long-term mortality across the spectrum of acute coronary syndromes. Am Heart J 2006;155:1065-1071.
Go to original source... - Griffith D, Hamilton K, Norrie J, et al. Early and late mortality after myocardial infarction in men and women: prospective observational study. Heart 2005;91:305-307.
Go to original source... - Antithrombotic Trialists (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet 2009;373:1849-1860.
Go to original source... - The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial. Lancet 2001;357:1385-1390.
Go to original source... - Dagenais GR, Pogue J, Fox K, et al. Angiotensin converting enzyme inhibitors in stable vascular disease without left ventricular dysfunction or heart failure: a combined analysis of three trials. Lancet 2006;368:581-588.
Go to original source... - Cholesterol Treatment Trialists Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 ramdomised trials of statins. Lancet 2005;366:1267-1278.
Go to original source... - Smith SC, Allen J, Blair SN, et al. AHA/ACC Guidelines for secondary prevention for patients with coronary and aother atherosclerotic vascular disease: 2006 Update: endorsed by the National Heart Blood and Lung Institute. Circulation 2006;113:2363-2372.
Go to original source... - Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504.
Go to original source... - Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST segment elevation. Eur Heart J 2011;32:2999-3054.
Go to original source... - Marchioli R, Marfisi RM, Carinci F, et al. Metaanalysis clinical trials, and transferability of research results into practice. The case of cholesterol - lowering interventions in the secondary prevention of coronary heart disease. Arch Intern Med 1996;156:1158-1172.
Go to original source... - Smith SC, Allen J, Blair SN. et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the national, heart, lung and blood institute. Circulation 2006;113:2363-2372.
Go to original source... - Kaluzay J, Remisova S, Pontuch P. Management and two-year prognosis of patients with acute myocardial infarction in a community hospital toward the end of thrombolytic era. Bratisl Lek Listy 2006;107(1-2):34-39.
- Hricak V, Janota T, Murin J, et al. Statíny u pacientov s akútnym koronárnym syndrómom. Konsenzus pracovných skupín akútnej kardiológie SKS a ČKS pre indikáciu a dávkovanie statínov. Cardiology Lett. 2011;20:500-501.

